4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001104659-22-032990
Director bought 634,638 shares at an average $12.86 ($8,158,671)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-03-09 | Purchase | +40,154 | $12.99 | $521,753 | 12,202,700 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-03-10 | Purchase | +256,992 | $12.95 | $3,327,584 | 12,459,692 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-03-11 | Purchase | +337,492 | $12.77 | $4,309,334 | 12,797,184 | I |
| Open-market purchases · 634,638 sh · avg $12.86 · $8,158,671 | |||||||
Loading xslF345X03/tm229063-1_4seq1.xml…